InsidersTradesSigma
Explore the full record of transactions filed by DAmour Kevin, Directeur Scientifique. Officer active across 1 company, notably Brooklyn ImmunoTherapeutics, Inc.. In total, 1 filings have been logged. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
DAmour Kevin is the Chief Scientific Officer at Brooklyn ImmunoTherapeutics, Inc. He is responsible for research and development initiatives, contributing to the innovation and growth of the company.